Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 5, May, p. 597–602

doi: 10.17219/acem/121508

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Macrophage migration inhibitory factor gene polymorphisms as exacerbating factors of apical periodontitis

Andrea Freer-Rojas1,A,B,D, Luis Carlos Martínez-Garibay1,A,B,D, Fernando Torres-Méndez1,A,C, Claudia Edith Dávila-Pérez1,A,C, Gabriel Alejandro Martínez-Castañón2,E,F, Nuria Patiño-Marín2,E,F, Jorge Alejandro Alegría-Torres3,4,A,C,D,E,F

1 Department of Endodontics, Dental School, Autonomous University of San Luis Potosí, Mexico

2 Clinical Research Laboratory, Program of Doctorate in Dental Sciences, Autonomous University of San Luis Potosí, Mexico

3 Department of Pharmacy, University of Guanajuato, Mexico

4 Molecular Nutrition Research Laboratory, LIMON, University of Central Mexico UCEM, San Luis Potosí, Mexico

Abstract

Background. Two polymorphisms in the macrophage migration inhibitory factor (MIF) gene have been associated with inflammatory diseases (-794 CATT5–8 and -173G>C); however, so far there are no reports of studies related to oral health.
Objectives. To genotype the -794 CATT5–8 and -173G>C MIF polymorphisms in Mexican patients with apical periodontitis as a genetic risk of exacerbation.
Material and Methods. The study involved 120 patients with apical periodontitis: 60 with a diagnosis of acute apical periodontitis (Group A) and 60 without previous episodes of exacerbation (Group B). Allelic discrimination was performed from peripheral blood DNA; the repeat polymorphism -794 CATT5–8 was genotyped with sequencing, while the -173G>C polymorphism was determined using real-time polymerase chain reaction (RT-PCR) using TaqMan probes. The associations between MIF polymorphisms, haplotypes and the risk of exacerbated apical periodontitis were assessed.
Results. The allele CATT7 was associated with the risk of a stage of acute inflammation (OR = 4.13; 95% CI = 1.82–9.63; p =< 0.001). Regarding the -173G >C polymorphism, a process of inflammation exacerbation was only associated with the CC genotype (OR = 4.1; 95% CI = 1.02–20.84; p = 0.045). The analysis of the haplotype showed that the combination CATT7/C increases the risk of exacerbation of apical periodontitis (OR = 3.57; 95% CI = 1.038–13.300; p = 0.021).
Conclusion. The polymorphisms -794 CATT5–8 and -173G>C MIF seem to significantly influence the development of a state of exacerbated inflammation in patients with apical periodontitis.

Key words

apical periodontitis, genetic polymorphisms, macrophage migration inhibitory factor

References (38)

  1. Nair PN. Apical periodontitis: A dynamic encounter between root canal infection and host response. Periodontol 2000. 1997;13:121–148.
  2. Kirkevang LL, Vaeth M, Hörsted-Bindslev P, Wenzel A. Longitudinal study of periapical and endodontic status in a Danish population. Int Endod J. 2006;39(2):100–107.
  3. Jiménez-Pinzón A, Segura-Egea JJ, Poyato-Ferrera M, Velasco-Ortega E, Ríos-Santos JV. Prevalence of apical periodontitis and frequency of root-filled teeth in an adult Spanish population. Int Endod J. 2004;37(3):167–173.
  4. Hussein FE, Liew AK, Ramlee RA, Abdullah D, Chong BS. Factors associated with apical periodontitis: A multilevel analysis. J Endod. 2016;42(10):1441–1445.
  5. Abbott PV. Classification, diagnosis and clinical manifestations of apical periodontitis. Endod Topics. 2014;8(1):36–54.
  6. Jakovljevic A, Knezevic A, Karalic D. Pro-inflammatory cytokine levels in human apical periodontitis: Correlation with clinical and histological findings. Aust Endod J. 2015;41(2):72–77.
  7. Calandra T, Roger T. Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol. 2003;3(10):791–800.
  8. Donn RP, Ray DW. Macrophage migration inhibitory factor: Molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol. 2004;182(1):1–9.
  9. Onodera S, Nishihira J, Iwabuchi K, et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts: Relevance to intracellular signaling pathways. J Biol Chem. 2010;277(10):7865–7874. doi:10.1074/jbc.M106020200
  10. Toh M, Aeberli D, Lacey D, et al. Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor. J Immunol. 2006;177(7):4818–4825.
  11. Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): A promising biomarker. Drug News Perspect. 2010;23(4):257–264.
  12. Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: Gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis. 2005;41(Suppl 7):S513–519.
  13. Baugh JA, Chitnis S, Donnelly SC. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun. 2002;3(3):170–176.
  14. Bucala R. MIF alleles and the regulation of the host response. In: Bucala R, ed. The MIF Handbook. Hackensack, NJ: World Scientific Publishing Company; 2012.
  15. Bucala R. MIF alleles, and prospects for therapeutic intervention in autoimmunity. J Clin Immunol. 2013;33(Suppl 1):S72–78.
  16. García-Sepulveda CA, Carrillo-Acuña E, Guerra-Palomares SE, Barriga-Moreno M. Maxiprep genomic DNA extractions for molecular epidemiology studies and biorepositories. Mol Biol Rep. 2010;37(4):1883–1890.
  17. Matia-García I, Salgado-Goytia L, Muñoz-Valle JF, et al. Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT 5-8 and -173 G>C): Relationship with mRNA expression and soluble MIF levels in young obese subjects. Dis Markers. 2015;461208. doi:10.1155/2015/461208
  18. Falvey JD, Bentley RW, Merriman TR, et al. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: An association study in New Zealand Caucasians and meta-analysis. World J Gastroenterol. 2013;19(39):6656–6664.
  19. Llamas-Covarrubias MA, Valle Y, Bucala R, et al. Macrophage migration inhibitory factor (MIF): Genetic evidence for participation in early onset and early stage rheumatoid arthritis. Cytokine. 2013;61(3):759–765.
  20. Valdés-Alvarado E, Muñoz-Valle JF, Valle Y, et al. Association between the -794 (CATT)5-8 MIF gene polymorphism and susceptibility to acute coronary syndrome in a Western Mexican population. J Immunol Res. 2014;2014:704854. doi:10.1155/2014/704854
  21. De la Cruz-Mosso U, Bucala R, Palafox-Sánchez CA, et al. Macrophage migration inhibitory factor: Association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus. Hum Immunol. 2014;75(5):433–439. doi:10.1016/j.humimm.2014.02.014
  22. Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U, et al. Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNFα in psoriatic arthritis. Int J Clin Exp Med. 2014;7(9):2605–2614.
  23. Martínez-Guzman MA, Alvarado-Navarro A, Pereira-Suarez AL, Muñoz-Valle JF, Fafutis-Morris M. Association between STR -794 CATT5-8 and SNP -173 G/C polymorphisms in the MIF gene and lepromatous leprosy in Mestizo patients of western Mexico. Hum Immunol. 2016;77(10):985–989. doi:10.1016/j.humimm.2016.07.006
  24. Ozsoy AZ, Karakus N, Tural S, et al. Influence of the MIF polymorphism -173G>C on Turkish postmenopausal women with osteoporosis. Z Rheumatol. 2017;77(7):629–632. doi:10.1007/s00393-017-0382-5
  25. Bossini-Castillo L, Campillo-Davó D, López-Isac E, et al; Spanish Scleroderma Group. An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis. J Rheumatol. 2017;44(10):1453–1457.
  26. Naderi M, Hashemi M, Ansari H. Macrophage migration inhibitory factor -173 G>C polymorphism and risk of tuberculosis: A meta-analysis. EXCLI J. 2017;16:313–320. doi:10.17179/excli2016-662
  27. Sadek KH, Ezzat S, Abdel-Aziz SA, Alaraby H, Mosbeh A, Abdel-Rahman MH. Macrophage migration inhibitory factor (MIF) gene promotor polymorphism is associated with increased fibrosis in biliary atresia patients, but not with disease susceptibility. Ann Hum Genet. 2017;81(5):177–183.
  28. Lin S, Wang M, Liu X, et al. Association of genetic polymorphisms in MIF with breast cancer risk in Chinese women. Clin Exp Med. 2017;17(3):395–301.
  29. El-Adly TZ, Kamal S, Selim H, Botros S. Association of macrophage migration inhibitory factor promoter polymorphism -173G/C with susceptibility to childhood asthma. Cent Eur J Immunol. 2016;41(3):268–272.
  30. Assis DN, Takahashi H, Leng L, Zeniya M, Boyer JL, Bucala R. A macrophage migration inhibitory factor polymorphism is associated with autoimmune hepatitis severity in US and Japanese patients. Dig Dis Sci. 2016;61(12):3506–3512.
  31. Lehmann LE, Book M, Hartmann W, et al. A MIF haplotype is associated with the outcome of patients with severe sepsis: A case control study. J Transl Med. 2009;7:100.
  32. Barton A, Lamb R, Symmons D, et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 2003;4(7):487–491.
  33. Qian L, Wang XY, Thapa S, et al. Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT5-8): Relationship with soluble MIF levels in coronary atherosclerotic disease subjects. BMC Cardiovasc Disord. 2017;17(1):144.
  34. Liu L, Peng B. The expression of macrophage migration inhibitory factor is correlated with receptor activator of nuclear factor kappa b ligand in induced rat apical lesions. J Endod. 2013;39(8):984–989.
  35. Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M, Ansarimoghaddam S, Moudi B, Sheibak N. Association of macrophage migration inhibitory factor gene polymorphisms with chronic periodontitis in a South Eastern Iranian population. Dent Res J (Isfahan). 2017;14(6):395–402.
  36. de Sá AR, Moreira PR, Xavier GM, et al. Association of CD14, IL1B, IL6, IL10 and TNFα functional gene polymorphisms with symptomatic dental abscesses. Int Endod J. 2007;40(7):563–572.
  37. Amaya MP, Criado L, Blanco B, et al. Polymorphisms of pro-inflammatory cytokine genes and the risk for acute suppurative or chronic nonsuppurative apical periodontitis in a Colombian population. Int Endod J. 2013;46(1):71–78.
  38. Aminoshariae A, Kulild JC. Association of functional gene polymorphism with apical periodontitis. J Endod. 2015;41(7):999–1007.
© Wroclaw Medical University